跳至主要内容
临床试验/IRCT20221216056834N1
IRCT20221216056834N1尚未招募3 期

A clinical trial comparing the effectiveness of probiotics along with standard three drug treatment and standard three drug treatment alone in eradicating Helicobacter pylori in dyspeptic patients between 15 and 45 years old with positive fecal antigen

Shahid Beheshti University of Medical Sciences0 个研究点目标入组 200 人开始时间: 待定最近更新:

试验速览

阶段
3 期
状态
尚未招募
入组人数
200

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
15 years 至 45 years(—)
性别
All

入选标准

  • age between 15-40 years
  • Verbal and written consent
  • symptoms of dyspepsia
  • Positive fecal Helicobacter pylori antigen test.

排除标准

  • use of any antibiotic in the last 2 weeks
  • consumption of pump inhibitor during the last 1 month
  • History of any proven malignancy
  • history of receiving Helicobacter pylori eradication regimen at any time in the past.

研究者

相似试验